SNY, BMY, REGN and others ramp up 2025 dealmaking as pharma/biotech giants chase innovation across key growth areas.

Enlicitide, which could be the first oral medication that blocks the protein PCSK9, helped cut cholesterol levels in a pair ...

The UK Financial Conduct Authority teams up with Nvidia to launch a powerful AI sandbox, giving financial firms access to ...

Oil prices dipped slightly on weak Chinese economic data, but broader market sentiment remains buoyant ahead of crucial ...